Los puntos clave no están disponibles para este artículo en este momento.
Introduction: Suicide is a global health concern that takes the lives of over 700,000 people each year. Suicide capability – including heightened pain tolerance and fearlessness about death – may explain the progression from suicidal ideation to a suicide attempt. Thus, investigating the neural circuitry associated with pain, fear, and suicide risk presents a unique opportunity to identify biomarkers of suicide capability and contribute to our understanding of the transition from suicidal ideation to suicide attempt. Methods: A total of 90 adults aged 18 to 65 will be recruited from Toronto, Canada. Participants will either be patients with current suicidal ideation but no previous suicide attempt (n=30), patients with current suicidal ideation and a suicide attempt within the past six months (n=30), or healthy controls (n=30). Participants will complete self-report measures and magnetic resonance imaging tasks measuring pain tolerance and fearlessness about death. Results: We expect that suicide attempters will exhibit significantly higher pain tolerance and fearlessness about death than suicide ideators or healthy controls. We also predict negative associations between self-reported suicide capability and pain- and fear-related neural activation. Discussion: Findings of the present study may contribute to the validation of ideation-to-action models of suicide by providing neurobiological evidence supporting the distinction between suicide ideators and attempters. Conclusion: By examining the neural underpinnings of suicide capability, our work contributes to the understanding of biomarkers indicating those at greatest risk of suicide.
Sarina Rain (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: